Why the study?
Does slow release oral verapamil increase dominant atrial cycle length in patients with chronic atrial fibrillation?
Does slow release oral verapamil increase dominant atrial cycle length in patients with chronic atrial fibrillation?
Long-term oral treatment with slow release verapamil significantly increases dominant atrial cycle length in patients with chronic atrial fibrillation, suggesting an attenuation of electrical remodeling.
No takes yet. Share an insight, caveat, or question.
Suggests verapamil may attenuate electrical remodeling in chronic AF; hypothesis-generating and needs prospective randomized confirmation.
Carl Meurling (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: